CPC Submits Letter to OMB Urging Release of Draft Guidance Outlining FDA’s Proposed Regulation of LDTs

The CPC sent a letter to OMB urging release of draft guidance outlining FDA’s proposed regulation of LDTs. The letter emphasizes the importance of the draft guidance in advancing discussion about optimal regulation of LDTs and IVDs and, possibly, a combined regulatory system.